Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-26-091536
Filing Date
2026-03-04
Accepted
2026-03-04 16:15:51
Documents
84
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K pepg-20251231.htm   iXBRL 10-K 3228300
2 EX-10.19 pepg-ex10_19.htm EX-10.19 146695
3 EX-10.20 pepg-ex10_20.htm EX-10.20 138208
4 EX-23.1 pepg-ex23_1.htm EX-23.1 3000
5 EX-31.1 pepg-ex31_1.htm EX-31.1 18642
6 EX-31.2 pepg-ex31_2.htm EX-31.2 18269
7 EX-32.1 pepg-ex32_1.htm EX-32.1 10535
8 EX-32.2 pepg-ex32_2.htm EX-32.2 10566
9 GRAPHIC img186162228_0.jpg GRAPHIC 186930
10 GRAPHIC img186162228_1.gif GRAPHIC 68809
11 GRAPHIC img186162228_2.jpg GRAPHIC 199545
12 GRAPHIC img186162228_3.jpg GRAPHIC 141048
  Complete submission text file 0001193125-26-091536.txt   13771518

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT pepg-20251231.xsd EX-101.SCH 1535691
86 EXTRACTED XBRL INSTANCE DOCUMENT pepg-20251231_htm.xml XML 2025860
Mailing Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210
Business Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210 703-456-8000
PepGen Inc. (Filer) CIK: 0001835597 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41374 | Film No.: 26721477
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)